Vivani Capex To Revenue vs Ev To Sales Analysis

VANI Stock

USD 1.33 0.04 3.10%

Vivani Medical financial indicator trend analysis is much more than just breaking down Vivani Medical prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Vivani Medical is a good investment. Please check the relationship between Vivani Medical Capex To Revenue and its Ev To Sales accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vivani Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

For more detail on how to invest in Vivani Stock please use our How to Invest in Vivani Medical guide.

Capex To Revenue vs Ev To Sales

Capex To Revenue vs Ev To Sales Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Vivani Medical Capex To Revenue account and Ev To Sales. At this time, the significance of the direction appears to have weak relationship.

The correlation between Vivani Medical's Capex To Revenue and Ev To Sales is 0.31. Overlapping area represents the amount of variation of Capex To Revenue that can explain the historical movement of Ev To Sales in the same time period over historical financial statements of Vivani Medical, assuming nothing else is changed. The correlation between historical values of Vivani Medical's Capex To Revenue and Ev To Sales is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Capex To Revenue of Vivani Medical are associated (or correlated) with its Ev To Sales. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Ev To Sales has no effect on the direction of Capex To Revenue i.e., Vivani Medical's Capex To Revenue and Ev To Sales go up and down completely randomly.

Correlation Coefficient

0.31

Relationship Direction	Positive
Relationship Strength	Very Weak

View All Relationships

Capex To Revenue

The ratio of a company's capital expenditures to its total revenue, indicating how much of the revenue is used for acquiring or maintaining physical assets.

Ev To Sales

The Enterprise Value to Sales ratio, a valuation metric used to compare the value of a company, including debt and excluding cash, to its sales revenue.

Most indicators from Vivani Medical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Vivani Medical current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vivani Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

For more detail on how to invest in Vivani Stock please use our How to Invest in Vivani Medical guide.The current Selling General Administrative is estimated to decrease to about 7.9 M. The current Issuance Of Capital Stock is estimated to decrease to about 126.3 K

	2021	2022	2023	2024 (projected)
Total Operating Expenses	13.3M	21.2M	27.0M	24.7M
Cost Of Revenue	345K	381K	357K	339.2K

Total Operating Expenses Cost Of Revenue

Vivani Medical fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Short Term Investments	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Short Term Debt	Common Stock	Other Liab
Total Assets		0.11	0.23	0.65	0.92	0.38	0.48	-0.6	0.05	0.18	0.69	0.41	0.39	0.94	0.14	0.59	0.52	0.14	0.21	0.74	0.39	0.27	0.94	0.51	-0.06	-0.28
Short Long Term Debt Total	0.11		-0.32	-0.23	-0.22	0.73	-0.25	0.43	0.31	-0.28	0.16	0.73	0.79	-0.05	-0.11	0.58	-0.06	1.0	-0.32	0.38	0.65	0.97	-0.07	0.52	-0.64	-0.74
Other Current Liab	0.23	-0.32		0.82	0.29	-0.13	0.11	-0.33	-0.9	0.73	0.09	-0.14	-0.26	0.21	0.49	-0.09	0.14	-0.3	0.42	0.21	0.22	-0.15	0.31	-0.24	0.83	0.12
Total Current Liabilities	0.65	-0.23	0.82		0.7	0.13	0.52	-0.47	-0.64	0.56	0.31	0.13	0.03	0.61	0.47	0.19	0.57	-0.22	0.54	0.51	0.4	-0.01	0.7	0.08	0.58	-0.13
Total Stockholder Equity	0.92	-0.22	0.29	0.7		0.2	0.55	-0.77	0.01	0.27	0.66	0.23	0.2	0.94	0.2	0.46	0.57	-0.2	0.28	0.67	0.21	-0.06	0.94	0.42	0.08	-0.15
Property Plant And Equipment Net	0.38	0.73	-0.13	0.13	0.2		-0.14	-0.02	0.19	-0.07	0.47	1.0	0.98	0.17	0.03	0.88	0.08	0.7	-0.34	0.71	0.92	0.76	0.14	0.87	-0.57	-0.94
Current Deferred Revenue	0.48	-0.25	0.11	0.52	0.55	-0.14		-0.03	-0.07	-0.18	-0.16	-0.14	-0.16	0.5	0.27	-0.19	0.93	-0.25	0.74	0.02	-0.07	-0.15	0.59	-0.16	0.2	0.12
Net Debt	-0.6	0.43	-0.33	-0.47	-0.77	-0.02	-0.03		0.05	-0.52	-0.82	-0.06	-0.01	-0.71	0.0	-0.4	-0.02	0.4	0.13	-0.55	0.01	0.31	-0.64	-0.37	-0.19	-0.03
Retained Earnings	0.05	0.31	-0.9	-0.64	0.01	0.19	-0.07	0.05		-0.62	0.19	0.21	0.35	0.07	-0.31	0.32	-0.1	0.3	-0.32	0.11	-0.18	0.16	-0.01	0.42	-0.89	-0.19
Accounts Payable	0.18	-0.28	0.73	0.56	0.27	-0.07	-0.18	-0.52	-0.62		0.36	-0.06	-0.13	0.24	-0.05	0.09	-0.15	-0.24	0.05	0.34	0.13	-0.13	0.27	-0.1	0.6	0.02
Cash	0.69	0.16	0.09	0.31	0.66	0.47	-0.16	-0.82	0.19	0.36		0.51	0.5	0.71	-0.11	0.8	-0.06	0.19	-0.39	0.81	0.37	0.27	0.62	0.73	-0.23	-0.42
Non Current Assets Total	0.41	0.73	-0.14	0.13	0.23	1.0	-0.14	-0.06	0.21	-0.06	0.51		0.99	0.2	0.02	0.9	0.07	0.69	-0.36	0.74	0.91	0.76	0.17	0.89	-0.58	-0.94
Non Currrent Assets Other	0.39	0.79	-0.26	0.03	0.2	0.98	-0.16	-0.01	0.35	-0.13	0.5	0.99		0.2	-0.03	0.91	0.05	0.76	-0.38	0.73	0.85	0.8	0.15	0.89	-0.69	-0.94
Cash And Short Term Investments	0.94	-0.05	0.21	0.61	0.94	0.17	0.5	-0.71	0.07	0.24	0.71	0.2	0.2		0.07	0.46	0.54	-0.01	0.19	0.64	0.16	0.11	0.98	0.38	0.02	-0.13
Net Receivables	0.14	-0.11	0.49	0.47	0.2	0.03	0.27	0.0	-0.31	-0.05	-0.11	0.02	-0.03	0.07		-0.01	0.25	-0.12	0.51	0.14	0.2	-0.04	0.2	-0.04	0.25	-0.08
Common Stock Shares Outstanding	0.59	0.58	-0.09	0.19	0.46	0.88	-0.19	-0.4	0.32	0.09	0.8	0.9	0.91	0.46	-0.01		0.0	0.57	-0.41	0.9	0.76	0.64	0.39	0.95	-0.57	-0.83
Short Term Investments	0.52	-0.06	0.14	0.57	0.57	0.08	0.93	-0.02	-0.1	-0.15	-0.06	0.07	0.05	0.54	0.25	0.0		-0.07	0.61	0.18	0.16	0.04	0.62	0.03	0.13	-0.14
Non Current Liabilities Total	0.14	1.0	-0.3	-0.22	-0.2	0.7	-0.25	0.4	0.3	-0.24	0.19	0.69	0.76	-0.01	-0.12	0.57	-0.07		-0.31	0.38	0.62	0.98	-0.04	0.49	-0.62	-0.71
Inventory	0.21	-0.32	0.42	0.54	0.28	-0.34	0.74	0.13	-0.32	0.05	-0.39	-0.36	-0.38	0.19	0.51	-0.41	0.61	-0.31		-0.09	-0.16	-0.24	0.36	-0.44	0.44	0.29
Other Current Assets	0.74	0.38	0.21	0.51	0.67	0.71	0.02	-0.55	0.11	0.34	0.81	0.74	0.73	0.64	0.14	0.9	0.18	0.38	-0.09		0.69	0.49	0.63	0.8	-0.3	-0.69
Other Stockholder Equity	0.39	0.65	0.22	0.4	0.21	0.92	-0.07	0.01	-0.18	0.13	0.37	0.91	0.85	0.16	0.2	0.76	0.16	0.62	-0.16	0.69		0.74	0.17	0.7	-0.24	-0.88
Total Liab	0.27	0.97	-0.15	-0.01	-0.06	0.76	-0.15	0.31	0.16	-0.13	0.27	0.76	0.8	0.11	-0.04	0.64	0.04	0.98	-0.24	0.49	0.74		0.1	0.53	-0.51	-0.77
Total Current Assets	0.94	-0.07	0.31	0.7	0.94	0.14	0.59	-0.64	-0.01	0.27	0.62	0.17	0.15	0.98	0.2	0.39	0.62	-0.04	0.36	0.63	0.17	0.1		0.3	0.11	-0.12
Short Term Debt	0.51	0.52	-0.24	0.08	0.42	0.87	-0.16	-0.37	0.42	-0.1	0.73	0.89	0.89	0.38	-0.04	0.95	0.03	0.49	-0.44	0.8	0.7	0.53	0.3		-0.66	-0.8
Common Stock	-0.06	-0.64	0.83	0.58	0.08	-0.57	0.2	-0.19	-0.89	0.6	-0.23	-0.58	-0.69	0.02	0.25	-0.57	0.13	-0.62	0.44	-0.3	-0.24	-0.51	0.11	-0.66		0.56
Other Liab	-0.28	-0.74	0.12	-0.13	-0.15	-0.94	0.12	-0.03	-0.19	0.02	-0.42	-0.94	-0.94	-0.13	-0.08	-0.83	-0.14	-0.71	0.29	-0.69	-0.88	-0.77	-0.12	-0.8	0.56

Click cells to compare fundamentals

Vivani Medical Account Relationship Matchups

Vivani Medical fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	16.6M	5.2M	5.5M	51.1M	45.8M	23.7M
Other Current Liab	5.3M	573K	895K	3.7M	2.4M	2.8M
Total Current Liabilities	7.0M	2.2M	2.1M	6.8M	5.7M	6.0M
Total Stockholder Equity	7.3M	2.0M	2.5M	44.3M	20.8M	13.0M
Property Plant And Equipment Net	3.5M	2.6M	2.8M	2.0M	21.3M	22.4M
Net Debt	(8.7M)	386K	(366K)	(44.1M)	42K	44.1K
Retained Earnings	(304.8M)	(46.1M)	(58.9M)	(72.8M)	(98.4M)	(103.4M)
Accounts Payable	1.1M	223K	281K	1.2M	542K	806.5K
Cash	11.3M	2.1M	2.2M	45.1M	20.7M	21.7M
Non Current Assets Total	3.5M	2.8M	3.0M	3.6M	22.7M	23.9M
Non Currrent Assets Other	37K	25K	200K	275K	1.4M	1.5M
Cash And Short Term Investments	11.3M	2.1M	2.2M	45.1M	20.7M	15.4M
Common Stock Shares Outstanding	4.9M	6.9M	11.0M	38.2M	50.9M	53.4M
Liabilities And Stockholders Equity	16.6M	5.2M	5.5M	51.1M	45.8M	23.7M
Other Current Assets	299K	348K	291K	2.5M	2.4M	2.5M
Other Stockholder Equity	48.6M	5.0M	6.7M	8.0M	119.1M	125.0M
Total Liab	9.3M	3.3M	3.0M	6.8M	25.0M	26.3M
Total Current Assets	13.1M	2.4M	2.5M	47.5M	23.1M	19.6M
Accumulated Other Comprehensive Income	(562K)	(448K)	(379K)	35K	140K	147K
Common Stock	264.0M	43.0M	54.6M	109.1M	5K	4.8K

Currently Active Assets on Macroaxis

F	Ford Motor
GOOG	Alphabet Inc Class C
CRM	Salesforce
V	Visa Class A
F	Ford Motor

When determining whether Vivani Medical offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Vivani Medical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Vivani Medical Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Vivani Medical Stock:

How To Invest In Vivani

Details

Is Vivani Stock a good investment?

Details

What is Vivani Medical's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vivani Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

For more detail on how to invest in Vivani Stock please use our How to Invest in Vivani Medical guide.

You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vivani Medical. If investors know Vivani will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vivani Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(0.43)

Return On Assets

(0.29)

Return On Equity

(0.86)

The market value of Vivani Medical is measured differently than its book value, which is the value of Vivani that is recorded on the company's balance sheet. Investors also form their own opinion of Vivani Medical's value that differs from its market value or its book value, called intrinsic value, which is Vivani Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vivani Medical's market value can be influenced by many factors that don't directly affect Vivani Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Vivani Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Vivani Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vivani Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Vivani Capex To Revenue vs Ev To Sales Analysis

Capex To Revenue vs Ev To Sales

Capex To Revenue vs Ev To Sales Correlation Analysis

Correlation Coefficient

Capex To Revenue

Ev To Sales

Vivani Medical fundamental ratios Correlations

Vivani Medical Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Vivani Medical fundamental ratios Accounts

Currently Active Assets on Macroaxis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Non Current Liabilities Total	+ 1.0	Short Long Term Debt Total
Non Current Assets Total	+ 1.0	Property Plant And Equipment Net
Non Currrent Assets Other	+ 0.99	Non Current Assets Total
Non Currrent Assets Other	+ 0.98	Property Plant And Equipment Net
Total Current Assets	+ 0.98	Cash And Short Term Investments
Total Liab	+ 0.98	Non Current Liabilities Total

Other Liab	- 0.94	Non Currrent Assets Other
Other Liab	- 0.94	Non Current Assets Total
Other Liab	- 0.94	Property Plant And Equipment Net
Retained Earnings	- 0.9	Other Current Liab
Common Stock	- 0.89	Retained Earnings
Other Liab	- 0.88	Other Stockholder Equity